About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 369172, 16 pages
http://dx.doi.org/10.1155/2013/369172
Review Article

The Immunologic Basis for Severe Neonatal Herpes Disease and Potential Strategies for Therapeutic Intervention

1Department of Pediatrics, Division of Infectious Diseases, University of Washington and Seattle Children’s Hospital, Seattle, WA 98105, USA
2Department of Pediatrics, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA

Received 4 January 2013; Accepted 6 March 2013

Academic Editor: Tobias R. Kollmann

Copyright © 2013 Soren Gantt and William J. Muller. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Wilson and T. Kollmann, “Induction of antigen-specific immunity in human neonates and infants,” Nestle Nutrition Workshop Series, vol. 61, pp. 183–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Levy, “Innate immunity of the newborn: basic mechanisms and clinical correlates,” Nature Reviews Immunology, vol. 7, no. 5, pp. 379–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ygberg and A. Nilsson, “The developing immune system—from foetus to toddler,” Acta Paediatrica, vol. 101, pp. 120–127, 2012.
  4. L. Corey and A. Wald, “Maternal and neonatal herpes simplex virus infections,” The New England Journal of Medicine, vol. 361, no. 14, pp. 1376–1385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. E. Pellett and B. Roizman, “The family herpesviridae: a brief introduction,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., pp. 2479–2499, Lippincott, Williams, & Wilkins, Philadelphia, Pa, USA, 2007.
  6. J. I. Cohen, “Introduction to Herpesviridae,” in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., pp. 1937–1942, Churchill-Livingstone Elsevier, Philadelphia, Pa, USA, 7th edition, 2009.
  7. L. Corey and P. G. Spear, “Infections with herpes simplex viruses,” The New England Journal of Medicine, vol. 314, no. 12, pp. 749–757, 1986. View at Scopus
  8. J. T. Schiffer and L. Corey, “New concepts in understanding genital herpes,” Current Infectious Disease Reports, vol. 11, no. 6, pp. 457–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. L. Schmitt, D. W. Johnson, and F. W. Henderson, “Herpes simplex type 1 infections in group day care,” Pediatric Infectious Disease Journal, vol. 10, no. 10, pp. 729–734, 1991. View at Scopus
  10. A. G. M. Langenberg, L. Corey, R. L. Ashley, W. P. Leong, and S. E. Straus, “A prospective study of new infections with herpes simplex virus type 1 and type 2,” The New England Journal of Medicine, vol. 341, no. 19, pp. 1432–1438, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. L. Sacks, P. D. Griffiths, L. Corey et al., “HSV shedding,” Antiviral Research, vol. 63, supplement 1, pp. S19–S26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Wald, J. Zeh, S. Selke et al., “Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons,” The New England Journal of Medicine, vol. 342, no. 12, pp. 844–850, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Koelle, J. Benedetti, A. Langenberg, and L. Corey, “Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes,” Annals of Internal Medicine, vol. 116, no. 6, pp. 433–437, 1992. View at Scopus
  14. K. E. Mark, A. Wald, A. S. Magaret et al., “Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults,” Journal of Infectious Diseases, vol. 198, no. 8, pp. 1141–1149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Xu, M. R. Sternberg, B. J. Kottiri et al., “Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States,” Journal of the American Medical Association, vol. 296, no. 8, pp. 964–973, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. T. Schiffer and L. Corey, “Herpes simplex virus,” in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, G. L. Mandell, J. E. Bennett, and R. Dolin, Eds., Churchill Livingstone, Philadelphia, Pa, USA, 7th edition, 2009.
  17. C. G. Prober, W. M. Sullender, and L. L. Yasukawa, “Low risk herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections,” The New England Journal of Medicine, vol. 316, no. 5, pp. 240–244, 1987. View at Scopus
  18. W. M. Sullender, J. L. Miller, and L. L. Yasukawa, “Humoral and cell-mediated immunity in neonates with herpes simplex virus infection,” Journal of Infectious Diseases, vol. 155, no. 1, pp. 28–37, 1987. View at Scopus
  19. Z. A. Brown, S. Selke, J. Zeh et al., “The acquisition of herpes simplex virus during pregnancy,” The New England Journal of Medicine, vol. 337, no. 8, pp. 509–515, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. E. L. Brown, R. Morrow, E. M. Krantz et al., “Maternal herpes simplex virus antibody avidity and risk of neonatal herpes,” American Journal of Obstetrics and Gynecology, vol. 195, no. 1, pp. 115–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. Ashley, J. Dalessio, S. Burchett et al., “Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth,” Journal of Clinical Investigation, vol. 90, no. 2, pp. 511–514, 1992. View at Scopus
  22. O. Kortekangas-Savolainen and T. Vuorinen, “Trends in herpes simplex virus type 1 and 2 infections among patients diagnosed with genital herpes in a Finnish sexually transmitted disease clinic, 1994–2002,” Sexually Transmitted Diseases, vol. 34, no. 1, pp. 37–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Bhattarakosol, S. Visaprom, A. Sangdara, and V. Mungmee, “Increase of genital HSV-1 and mixed HSV-1 and HSV-2 infection in Bangkok, Thailand,” Journal of the Medical Association of Thailand, vol. 88, pp. S300–S304, 2005. View at Scopus
  24. L. J. Haddow, B. Dave, A. Mindel et al., “Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003,” Sexually Transmitted Infections, vol. 82, no. 3, pp. 255–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Tran, J. D. Druce, M. C. Catton, H. Kelly, and C. J. Birch, “Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003,” Sexually Transmitted Infections, vol. 80, no. 4, pp. 277–279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Manavi, A. McMillan, and M. Ogilvie, “Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in edinburgh, Scotland,” Sexually Transmitted Diseases, vol. 31, no. 5, pp. 322–324, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Horowitz, S. Aierstuck, E. A. Williams, and B. Melby, “Herpes simplex virus infection in a university health population: clinical manifestations, epidemiology, and implications,” Journal of American College Health, vol. 59, no. 2, pp. 69–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. S. Pereira, R. N. Moizeis, T. A. Fernandes, J. M. Araujo, R. V. Meissner, et al., “Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 161, pp. 190–193, 2012.
  29. D. I. Bernstein, A. R. Bellamy, E. W. Hook, M. J. Levin, A. Wald, et al., “Epidemiology, clinical presentation and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women,” Clinical Infectious Diseases, vol. 56, no. 3, pp. 344–351, 2013. View at Publisher · View at Google Scholar
  30. R. Gupta, T. Warren, and A. Wald, “Genital herpes,” The Lancet, vol. 370, no. 9605, pp. 2127–2137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. W. C. Reeves, L. Corey, and H. G. Adams, “Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response,” The New England Journal of Medicine, vol. 305, no. 6, pp. 315–319, 1981. View at Scopus
  32. L. Corey, A. Mindel, and K. H. Fife, “Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir,” Sexually Transmitted Diseases, vol. 12, no. 4, pp. 215–218, 1985. View at Scopus
  33. A. Mindel, I. V. D. Weller, and A. Faherty, “Acyclovir in first attacks of genital herpes and prevention of recurrences,” Genitourinary Medicine, vol. 62, no. 1, pp. 28–32, 1986. View at Scopus
  34. J. W. Fluhr, R. Darlenski, A. Taieb et al., “Functional skin adaptation in infancy—almost complete but not fully competent,” Experimental Dermatology, vol. 19, no. 6, pp. 483–492, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. P. Walker, H. T. Akinbi, J. Meinzen-Derr, V. Narendran, M. Visscher, and S. B. Hoath, “Host defense proteins on the surface of neonatal skin: implications for innate immunity,” Journal of Pediatrics, vol. 152, no. 6, pp. 777–781, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. R. A. Dorschner, K. H. Lin, M. Murakami, and R. L. Gallo, “Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response,” Pediatric Research, vol. 53, no. 4, pp. 566–572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Murakami, T. Ohtake, R. A. Dorschner, and R. L. Gallo, “Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva,” Journal of Dental Research, vol. 81, no. 12, pp. 845–850, 2002. View at Scopus
  38. A. Orvedahl and B. Levine, “Autophagy and viral neurovirulence,” Cellular Microbiology, vol. 10, no. 9, pp. 1747–1756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Orvedahl, D. Alexander, Z. Tallóczy et al., “HSV-1 ICP34.5 confers neurovirulence by targeting the beclin 1 autophagy protein,” Cell Host and Microbe, vol. 1, no. 1, pp. 23–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Lussignol, C. Queval, M. F. Bernet-Camard, J. Cotte-Laffitte, I. Beau, et al., “The herpes simplex virus type 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR,” Journal of Virology, vol. 87, pp. 859–871, 2013.
  41. C. S. Shi and J. H. Kehrl, “MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages,” Journal of Biological Chemistry, vol. 283, no. 48, pp. 33175–33182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Delgado and V. Deretic, “Toll-like receptors in control of immunological autophagy,” Cell Death and Differentiation, vol. 16, no. 7, pp. 976–983, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Melchjorsen, “Sensing herpes: more than toll,” Reviews in Medical Virology, vol. 22, pp. 106–121, 2012.
  44. N. Martinez-Martin and A. Viejo-Borbolla, “Toll-like receptor-mediated recognition of herpes simplex virus,” Frontiers in Bioscience, vol. 2, pp. 718–729, 2010. View at Scopus
  45. T. R. Kollmann, J. Crabtree, A. Rein-Weston et al., “Neonatal innate TLR-mediated responses are distinct from those of adults,” Journal of Immunology, vol. 183, no. 11, pp. 7150–7160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. T. R. Kollmann, O. Levy, R. R. Montgomery, and S. Goriely, “Innate immune function by toll-like receptors: distinct responses in newborns and the elderly,” Immunity, vol. 37, pp. 771–783, 2012.
  47. O. Levy, S. Goriely, and T. R. Kollmann, “Immune response to vaccine adjuvants during the first year of life,” Vaccine, 2012. View at Publisher · View at Google Scholar
  48. S. C. Diesner, E. Forster-Waldl, A. Olivera, A. Pollak, E. Jensen-Jarolim, et al., “Perspectives on immunomodulation early in life,” Pediatric Allergy and Immunology, vol. 23, pp. 210–223, 2012.
  49. S. Jawahar, C. Moody, M. Chan, R. Finberg, R. Geha, and T. Chatila, “Natural killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II),” Clinical and Experimental Immunology, vol. 103, no. 3, pp. 408–413, 1996. View at Scopus
  50. C. A. Biron, K. S. Byron, and J. L. Sullivan, “Severe herpesvirus infections in an adolescent without natural killer cells,” The New England Journal of Medicine, vol. 320, no. 26, pp. 1731–1735, 1989. View at Scopus
  51. S. E. Chisholm, K. Howard, M. V. Gómez, and H. T. Reyburn, “Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors,” Journal of Infectious Diseases, vol. 195, no. 8, pp. 1160–1168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Kohl, L. S. Loo, and B. Gonik, “Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells,” Journal of Infectious Diseases, vol. 150, no. 1, pp. 14–19, 1984. View at Scopus
  53. S. Kohl, M. S. West, and L. S. Loo, “Defects in interleukin-2 stimulation of neonatal killer cytotoxicity to herpes simplex virus-infected cells,” Journal of Pediatrics, vol. 112, no. 6, pp. 976–981, 1988. View at Scopus
  54. J. P. Frazier, S. Kohl, L. K. Pickering, and L. S. Loo, “The effect of route of delivery on neonatal natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells,” Pediatric Research, vol. 16, no. 7, pp. 558–560, 1982. View at Scopus
  55. M. R. Verneris and J. S. Miller, “The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells,” British Journal of Haematology, vol. 147, no. 2, pp. 185–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zhu, D. M. Koelle, J. Cao et al., “Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation,” Journal of Experimental Medicine, vol. 204, no. 3, pp. 595–603, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. J. T. Schiffer, L. Abu-Raddad, K. E. Mark et al., “Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 44, pp. 18973–18978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. R. F. Pass, M. E. Dworsky, and R. J. Whitley, “Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy,” Infection and Immunity, vol. 34, no. 1, pp. 166–170, 1981. View at Scopus
  59. A. R. Hayward, M. J. Herberger, J. Groothuis, and M. R. Levin, “Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus,” Journal of Immunology, vol. 133, no. 5, pp. 2469–2473, 1984. View at Scopus
  60. S. K. Burchett, L. Corey, K. M. Mohan, J. Westall, R. Ashley, and C. B. Wilson, “Diminished interferon-γ and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection,” Journal of Infectious Diseases, vol. 165, no. 5, pp. 813–818, 1992. View at Scopus
  61. C. A. Siegrist, “Neonatal and early life vaccinology,” Vaccine, vol. 19, no. 25-26, pp. 3331–3346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Marchant and M. Goldman, “T cell-mediated immune responses in human newborns: ready to learn?” Clinical and Experimental Immunology, vol. 141, no. 1, pp. 10–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Johnston, D. M. Koelle, and A. Wald, “HSV-2: in pursuit of a vaccine,” The Journal of Clinical Investigation, vol. 121, pp. 4600–4609, 2011.
  64. S. S. Wilson, E. Fakioglu, and B. C. Herold, “Novel approaches in fighting herpes simplex virus infections,” Expert Review of Anti-Infective Therapy, vol. 7, no. 5, pp. 559–568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Lundberg, C. Ramakrishna, J. Brown et al., “The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis,” Journal of Virology, vol. 82, no. 14, pp. 7078–7088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Ramakrishna, A. N. S. Newo, Y. W. Shen, and E. Cantin, “Passively administered pooled human immunoglobulins exert il-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis,” PLoS Pathogens, vol. 7, no. 6, Article ID e1002071, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. S. J. Kopp, A. H. Karaba, L. K. Cohen, G. Banisadr, R. J. Miller, et al., “Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation,” Journal of Virology, vol. 87, pp. 474–481, 2013.
  68. M. T. Fitch and D. van de Beek, “Drug Insight: steroids in CNS infectious diseases—new indications for an old therapy,” Nature Clinical Practice Neurology, vol. 4, no. 2, pp. 97–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Nagamori, S. Koyano, Y. Asai, F. Nohara, T. Okamoto, et al., “Sequential changes in pathophysiology of systemic inflammatory response in a disseminated neonatal herpes simplex virus (HSV) infection,” Journal of Clinical Virology, vol. 53, pp. 265–267, 2012.
  70. S. Kamei, T. Sekizawa, H. Shiota et al., “Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 11, pp. 1544–1549, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Vollstedt, M. Franchini, H. P. Hefti et al., “Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections,” Journal of Experimental Medicine, vol. 197, no. 5, pp. 575–584, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. M. A. Jenabian, P. Ancuta, N. Gilmore, and J. P. Routy, “Regulatory T cells in HIV infection: can immunotherapy regulate the regulator?” Clinical & Developmental Immunology, vol. 2012, Article ID 908314, 12 pages, 2012. View at Publisher · View at Google Scholar
  73. M. A. Curran, W. Montalvo, H. Yagita, and J. P. Allison, “PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 9, pp. 4275–4280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. A. J. Montero, C. M. Diaz-Montero, C. E. Kyriakopoulos, V. Bronte, and S. Mandruzzato, “Myeloid-derived suppressor cells in cancer patients: a clinical perspective,” Journal of Immunotherapy, vol. 35, pp. 107–115, 2012.
  75. J. M. Lund, L. Hsing, T. T. Pham, and A. Y. Rudensky, “Coordination of early protective immunity to viral infection by regulatory T cells,” Science, vol. 320, no. 5880, pp. 1220–1224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. D. C. Rubinsztein, P. Codogno, and B. Levine, “Autophagy modulation as a potential therapeutic target for diverse diseases,” Nature Reviews Drug Discovery, vol. 11, pp. 709–730, 2012.
  77. S. Gantt, J. Carlsson, M. Ikoma et al., “The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 6, pp. 2696–2703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Pei, Z. P. Chen, H. Q. Ju et al., “Autophagy is involved in anti-viral activity of pentagalloylglucose (PGG) against Herpes simplex virus type 1 infection in vitro,” Biochemical and Biophysical Research Communications, vol. 405, no. 2, pp. 186–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. G. T. Vasileiadis, H. W. Roukema, W. Romano, J. C. Walton, and R. Gagnon, “Intrauterine herpes simplex infection,” American Journal of Perinatology, vol. 20, no. 2, pp. 55–58, 2003. View at Scopus
  80. C. Hutto, A. Arvin, and R. Jacobs, “Intrauterine herpes simplex virus infections,” Journal of Pediatrics, vol. 110, no. 1, pp. 97–101, 1987. View at Scopus
  81. D. W. Kimberlin, “Neonatal herpes simplex infection,” Clinical Microbiology Reviews, vol. 17, no. 1, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. W. J. Muller, C. A. Jones, and D. M. Koelle, “Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn,” Current Immunology Reviews, vol. 6, no. 1, pp. 38–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Johnston, A. Magaret, S. Selke, M. Remington, L. Corey, and A. Wald, “Herpes simplex virus viremia during primary genital infection,” Journal of Infectious Diseases, vol. 198, no. 1, pp. 31–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. A. H. Kang and C. R. Graves, “Herpes simplex hepatitis in pregnancy: a case report and review of the literature,” Obstetrical and Gynecological Survey, vol. 54, no. 7, pp. 463–468, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. L. Pereira, E. Maidji, S. McDonagh, O. Genbacev, and S. Fisher, “Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity,” Journal of Virology, vol. 77, no. 24, pp. 13301–13314, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. S. McDonagh, E. Maidji, W. Ma, H. T. Chang, S. Fisher, and L. Pereira, “Viral and bacterial pathogens at the maternal-fetal interface,” Journal of Infectious Diseases, vol. 190, no. 4, pp. 826–834, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. D. W. Kimberlin, “Herpes simplex virus infections of the newborn,” Seminars in Perinatology, vol. 31, no. 1, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. D. W. Kimberlin, C. Y. Lin, R. F. Jacobs et al., “Natural history of neonatal herpes simplex virus infections in the acyclovir era,” Pediatrics, vol. 108, no. 2, pp. 223–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Whitley, A. Arvin, C. Prober et al., “Predictors of morbidity and mortality in neonates with herpes simplex virus infections,” The New England Journal of Medicine, vol. 324, no. 7, pp. 450–454, 1991. View at Scopus
  90. L. Corey, E. F. Stone, R. J. Whitley, and K. Mohan, “Differrence between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome,” The Lancet, vol. 1, no. 8575-8576, pp. 1–4, 1988. View at Scopus
  91. D. W. Kimberlin, C. Y. Lin, R. F. Jacobs et al., “Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections,” Pediatrics, vol. 108, no. 2, pp. 230–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. D. W. Kimberlin, R. J. Whitley, W. Wan, D. A. Powell, G. Storch, et al., “Oral acyclovir suppression and neurodevelopment after neonatal herpes,” The New England Journal of Medicine, vol. 365, pp. 1284–1292, 2011.
  93. H. Jenssen, “Therapeutic approaches using host defence peptides to tackle herpes virus infections,” Viruses, vol. 1, pp. 939–964, 2009.
  94. J. Melchjorsen, S. Matikainen, and S. R. Paludan, “Activation and evasion of innate antiviral immunity by herpes simplex virus,” Viruses, vol. 1, pp. 737–759, 2009.
  95. R. J. Duerst and L. A. Morrison, “Innate immunity to herpes simplex virus type 2,” Viral Immunology, vol. 16, no. 4, pp. 475–490, 2003. View at Scopus
  96. K. L. Mossman and A. A. Ashkar, “Herpesviruses and the innate immune response,” Viral Immunology, vol. 18, no. 2, pp. 267–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. D. M. Koelle and L. Corey, “Recent progress in herpes simplex virus immunobiology and vaccine research,” Clinical Microbiology Reviews, vol. 16, no. 1, pp. 96–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. K. M. Khanna, A. J. Lepisto, V. Decman, and R. L. Hendricks, “Immune control of herpes simplex virus during latency,” Current Opinion in Immunology, vol. 16, no. 4, pp. 463–469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Kohl, “Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus,” Reviews of Infectious Diseases, vol. 13, supplement 11, pp. S950–S952, 1991. View at Scopus
  100. P. Y. Ong, T. Ohtake, C. Brandt et al., “Endogenous antimicrobial peptides and skin infections in atopic dermatitis,” The New England Journal of Medicine, vol. 347, no. 15, pp. 1151–1160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Wollenberg, S. Wetzel, W. H. C. Burgdorf, and J. Haas, “Viral infections in atopic dermatitis: pathogenic aspects and clinical management,” Journal of Allergy and Clinical Immunology, vol. 112, no. 4, pp. 667–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Herman, M. Ciancanelli, Y. H. Ou, L. Lorenzo, M. Klaudel-Dreszler, et al., “Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood,” Journal of Experimental Medicine, vol. 209, pp. 1567–1582, 2012.
  103. A. Casrouge, S. Y. Zhang, C. Eidenschenk et al., “Herpes simplex virus encephalitis in human UNC-93B deficiency,” Science, vol. 314, no. 5797, pp. 308–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. R. Pérez de Diego, V. Sancho-Shimizu, L. Lorenzo et al., “Human TRAF3 adaptor molecule deficiency leads to impaired toll-like receptor 3 response and susceptibility to herpes simplex encephalitis,” Immunity, vol. 33, no. 3, pp. 400–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. V. Sancho-Shimizu, R. Perez de Diego, L. Lorenzo, R. Halwani, A. Alangari, et al., “Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency,” The Journal of Clinical Investigation, vol. 121, pp. 4889–4902, 2011.
  106. S. Y. Zhang, E. Jouanguy, S. Ugolini et al., “TLR3 deficiency in patients with herpes simplex encephalitis,” Science, vol. 317, no. 5844, pp. 1522–1527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. Y. Guo, M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo, et al., “Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity,” The Journal of Experimental Medicine, vol. 208, pp. 2083–2098, 2011.
  108. S. Dupuis, E. Jouanguy, S. Al-Hajjar et al., “Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency,” Nature Genetics, vol. 33, no. 3, pp. 388–391, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. Minegishi, M. Saito, T. Morio et al., “Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity,” Immunity, vol. 25, no. 5, pp. 745–755, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Niehues, J. Reichenbach, J. Neubert et al., “Nuclear factor κB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia,” Journal of Allergy and Clinical Immunology, vol. 114, no. 6, pp. 1456–1462, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. Q. Zhang, J. C. Davis, I. T. Lamborn et al., “Combined immunodeficiency associated with DOCK8 mutations,” The New England Journal of Medicine, vol. 361, no. 21, pp. 2046–2055, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. L. Abbo, V. Vincek, G. Dickinson, N. Shrestha, S. Doblecki, and P. A. Haslett, “Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod,” Clinical Infectious Diseases, vol. 44, no. 3, pp. e25–e27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Dalloul, E. Oksenhendler, O. Chosidow et al., “Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood,” Journal of Clinical Virology, vol. 30, no. 4, pp. 329–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Pollara, K. Speidel, L. Samady et al., “Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity,” Journal of Infectious Diseases, vol. 187, no. 2, pp. 165–178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. X. Zhao, E. Deak, K. Soderberg et al., “Vaginal submucosal dendritic cells, but not langerhans cells, induce protective Th1 responses to herpes simplex virus-2,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 153–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. R. S. Allan, C. M. Smith, G. T. Belz et al., “Epidermal viral immunity induced by CD8α+ dendritic cells but not by langerhans cells,” Science, vol. 301, no. 5641, pp. 1925–1928, 2003. View at Publisher · View at Google Scholar · View at Scopus
  117. R. S. Allan, J. Waithman, S. Bedoui et al., “Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming,” Immunity, vol. 25, no. 1, pp. 153–162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  118. H. K. Lee, M. Zamora, M. M. Linehan et al., “Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection,” Journal of Experimental Medicine, vol. 206, no. 2, pp. 359–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. N. J. Moss, A. Magaret, K. J. Laing, A. S. Kask, M. Wang, et al., “Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes,” Journal of Virology, vol. 86, pp. 9952–9963, 2012.
  120. N. Hosken, P. McGowan, A. Meier et al., “Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes,” Journal of Virology, vol. 80, no. 11, pp. 5509–5515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. Y. Nakanishi, B. Lu, C. Gerard, and A. Iwasaki, “CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help,” Nature, vol. 462, no. 7272, pp. 510–513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. K. M. Khanna, R. H. Bonneau, P. R. Kinchington, and R. L. Hendricks, “Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia,” Immunity, vol. 18, no. 5, pp. 593–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Liu, K. M. Khanna, X. Chen, D. J. Fink, and R. L. Hendricks, “CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons,” Journal of Experimental Medicine, vol. 191, no. 9, pp. 1459–1466, 2000. View at Publisher · View at Google Scholar · View at Scopus
  124. M. L. Freeman, B. S. Sheridan, R. H. Bonneau, and R. L. Hendricks, “Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections,” Journal of Immunology, vol. 179, no. 1, pp. 322–328, 2007. View at Scopus
  125. A. L. Cunningham, R. R. Turner, and A. C. Miller, “Evolution of recurrent herpes simplex lesions. An immunohistologic study,” Journal of Clinical Investigation, vol. 75, no. 1, pp. 226–233, 1985. View at Scopus
  126. D. M. Koelle, C. M. Posavad, G. R. Barnum, M. L. Johnson, J. M. Frank, et al., “Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes,” Journal of Clinical Investigation, vol. 101, pp. 1500–1508, 1998.
  127. N. Iijima, M. M. Linehan, M. Zamora et al., “Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus,” Journal of Experimental Medicine, vol. 205, no. 13, pp. 3041–3052, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. L. M. Wakim, J. Waithman, N. Van Rooijen, W. R. Heath, and F. R. Carbone, “Dendritic cell-induced memory T cell activation in nonlymphoid tissues,” Science, vol. 319, no. 5860, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Peng, J. Zhu, K. Phasouk, D. M. Koelle, A. Wald, et al., “An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection,” Journal of Virology, vol. 86, pp. 10587–10596, 2012.
  130. L. N. Sørensen, L. S. Reinert, L. Malmgaard, C. Bartholdy, A. R. Thomsen, and S. R. Paludan, “TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain,” Journal of Immunology, vol. 181, no. 12, pp. 8604–8612, 2008. View at Scopus
  131. E. A. Kurt-Jones, M. Chan, S. Zhou et al., “Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 5, pp. 1315–1320, 2004. View at Publisher · View at Google Scholar · View at Scopus
  132. R. J. Soberman, C. R. Mackay, C. A. Vaine, G. B. Ryan, A. M. Cerny, et al., “CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2,” PloS ONE, vol. 7, Article ID e47740, 2012.
  133. U. K. Meyding-Lamade, C. Oberlinner, P. R. Rau et al., “Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities,” Journal of NeuroVirology, vol. 9, no. 1, pp. 118–125, 2003. View at Scopus
  134. I. J. MacLeod and T. Minson, “Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry,” PloS ONE, vol. 5, no. 3, Article ID e9560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Yoon, S. J. Kopp, J. M. Taylor, C. S. Storti, P. G. Spear, and W. J. Muller, “Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infection,” PloS ONE, vol. 6, no. 1, Article ID e16122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  136. M. G. Santoro, A. Rossi, and C. Amici, “NF-κB and virus infection: who controls whom,” EMBO Journal, vol. 22, no. 11, pp. 2552–2560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. J. R. Smiley, “Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?” Journal of Virology, vol. 78, no. 3, pp. 1063–1068, 2004. View at Publisher · View at Google Scholar · View at Scopus
  138. H. M. Friedman, G. H. Cohen, and R. J. Eisenberg, “Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells,” Nature, vol. 309, no. 5969, pp. 633–635, 1984. View at Scopus
  139. J. Lubinski, L. Wang, D. Mastellos, A. Sahu, J. D. Lambris, and H. M. Friedman, “In vivo role of complement-interacting domains of herpes simplex virus type 1 gC,” Journal of Experimental Medicine, vol. 190, no. 11, pp. 1637–1646, 1999. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Lubinski, T. Nagashunmugam, and H. M. Friedman, “Viral interference with antibody and complement,” Seminars in Cell and Developmental Biology, vol. 9, no. 3, pp. 329–337, 1998. View at Scopus
  141. K. Ahn, T. H. Meyer, S. Uebel et al., “Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47,” EMBO Journal, vol. 15, no. 13, pp. 3247–3255, 1996. View at Scopus
  142. K. Fruh, K. Ahn, H. Djaballah et al., “A viral inhibitor of peptide transporters for antigen presentation,” Nature, vol. 375, no. 6530, pp. 415–418, 1995. View at Scopus
  143. A. Hill, P. Juovic, I. York et al., “Herpes simplex virus turns off the TAP to evade host immunity,” Nature, vol. 375, no. 6530, pp. 411–415, 1995. View at Scopus
  144. B. Levine, N. Mizushima, and H. W. Virgin, “Autophagy in immunity and inflammation,” Nature, vol. 469, no. 7330, pp. 323–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. B. Yordy, N. Iijima, A. Huttner, D. Leib, and A. Iwasaki, “A neuron-specific role for autophagy in antiviral defense against herpes simplex virus,” Cell Host & Microbe, vol. 12, pp. 334–345, 2012.
  146. N. P. Corbett, D. Blimkie, K. C. Ho et al., “Ontogeny of toll-like receptor mediated cytokine responses of human blood mononuclear cells,” PloS ONE, vol. 5, no. 11, Article ID e15041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. O. Vosters, C. Lombard, F. André, G. Sana, E. M. Sokal, and F. Smets, “The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life,” Clinical and Experimental Immunology, vol. 162, no. 3, pp. 494–499, 2010. View at Scopus
  148. S. Burl, J. Townend, J. Njie-Jobe et al., “Age-dependent maturation of toll-like receptor-mediated cytokine responses in gambian infants,” PloS ONE, vol. 6, no. 4, Article ID e18185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. B. J. Marais, “Childhood tuberculosis: epidemiology and natural history of disease,” Indian Journal of Pediatrics, vol. 78, no. 3, pp. 321–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. C. B. Wilson, “Immunologic basis for increased susceptibility of the neonate to infection,” Journal of Pediatrics, vol. 108, no. 1, pp. 1–12, 1986. View at Scopus
  151. P. R. Donald, B. J. Marais, and C. E. Barry, “Age and the epidemiology and pathogenesis of tuberculosis,” The Lancet, vol. 375, no. 9729, pp. 1852–1854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. A. Makrigiannakis, G. Petsas, B. Toth, K. Relakis, and U. Jeschke, “Recent advances in understanding immunology of reproductive failure,” Journal of Reproductive Immunology, vol. 90, no. 1, pp. 96–104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. J. S. Hunt, M. G. Petroff, R. H. McIntire, and C. Ober, “HLA-G and immune tolerance in pregnancy,” FASEB Journal, vol. 19, no. 7, pp. 681–693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. J. Szekeres-Bartho, “Regulation of NK cell cytotoxicity during pregnancy,” Reproductive BioMedicine Online, vol. 16, no. 2, pp. 211–217, 2008. View at Scopus
  155. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, “Regulatory T cells mediate maternal tolerance to the fetus,” Nature Immunology, vol. 5, no. 3, pp. 266–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  156. D. A. Somerset, Y. Zheng, M. D. Kilby, D. M. Sansom, and M. T. Drayson, “Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset,” Immunology, vol. 112, no. 1, pp. 38–43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. R. M. Samstein, S. Z. Josefowicz, A. Arvey, P. M. Treuting, and A. Y. Rudensky, “Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict,” Cell, vol. 150, pp. 29–38, 2012.
  158. J. E. Mold, J. Michaëlsson, T. D. Burt et al., “Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero,” Science, vol. 322, no. 5907, pp. 1562–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. J. H. Rowe, J. M. Ertelt, L. Xin, and S. S. Way, “Pregnancy imprints regulatory memory that sustains anergy to fetal antigen,” Nature, vol. 490, pp. 102–106, 2012.
  160. L. Chabtini, B. Mfarrej, M. Mounayar, B. Zhu, I. Batal, et al., “TIM-3 regulates innate immune cells to induce fetomaternal tolerance,” Journal of Immunology, vol. 190, pp. 88–96, 2013.
  161. I. Roth, D. B. Corry, R. M. Locksley, J. S. Abrams, M. J. Litton, and S. J. Fisher, “Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10,” Journal of Experimental Medicine, vol. 184, no. 2, pp. 539–548, 1996. View at Scopus
  162. J. Szekeres-Bartho, Z. Faust, P. Varga, L. Szereday, and K. Kelemen, “The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production,” American Journal of Reproductive Immunology, vol. 35, no. 4, pp. 348–351, 1996. View at Scopus
  163. Z. A. Brown, A. Wald, R. A. Morrow, S. Selke, J. Zeh, and L. Corey, “Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant,” Journal of the American Medical Association, vol. 289, no. 2, pp. 203–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  164. G. Marchini, S. Lindow, H. Brismar et al., “The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa,” British Journal of Dermatology, vol. 147, no. 6, pp. 1127–1134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  165. H. Yoshio, M. Tollin, G. H. Gudmundsson et al., “Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense,” Pediatric Research, vol. 53, no. 2, pp. 211–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  166. H. Yoshio, H. Lagercrantz, G. H. Gudmundsson, and B. Agerberth, “First line of defense in early human life,” Seminars in Perinatology, vol. 28, no. 4, pp. 304–311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  167. T. Strunk, A. Currie, P. Richmond, K. Simmer, and D. Burgner, “Innate immunity in human newborn infants: prematurity means more than immaturity,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  168. F. Cecconi, S. Di Bartolomeo, R. Nardacci et al., “A novel role for autophagy in neurodevelopment,” Autophagy, vol. 3, no. 5, pp. 506–508, 2007. View at Scopus
  169. M. T. Viscomi and M. D'Amelio, “The, “janus-faced role” of autophagy in neuronal sickness: focus on neurodegeneration,” Molecular Neurobiology, vol. 46, pp. 513–521, 2012.
  170. J. G. Lisciandro, S. L. Prescott, M. G. Nadal-Sims, C. J. Devitt, W. Pomat, et al., “Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants,” PloS ONE, vol. 7, Article ID e36793, 2012.
  171. D. De Wit, S. Tonon, V. Olislagers et al., “Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood,” Journal of Autoimmunity, vol. 21, no. 3, pp. 277–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  172. B. Cederblad and G. V. Alm, “Infrequent but efficient interferon-α-producing human mononuclear leukocytes induced by herpes simplex virus in vitro studied by immuno-plaque and limiting dilution assays,” Journal of Interferon Research, vol. 10, no. 1, pp. 65–73, 1990. View at Scopus
  173. M. E. Belderbos, O. Levy, F. Stalpers, J. L. Kimpen, L. Meyaard, et al., “Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors,” PloS ONE, vol. 7, Article ID e33419, 2012.
  174. W. Al-Hertani, R. Y. Sen, D. M. Byers, and R. Bortolussi, “Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide,” Clinical and Investigative Medicine, vol. 30, no. 2, pp. E44–E53, 2007. View at Scopus
  175. S. R. Yan, G. Qing, D. M. Byers, A. W. Stadnyk, W. Al-Hertani, and R. Bortolussi, “Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide,” Infection and Immunity, vol. 72, no. 3, pp. 1223–1229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  176. P. P. Sarangi, B. Kim, E. Kurt-Jones, and B. T. Rouse, “Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis,” Journal of Virology, vol. 81, no. 20, pp. 11128–11138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  177. B. Danis, T. C. George, S. Goriely et al., “Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells,” European Journal of Immunology, vol. 38, no. 2, pp. 507–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  178. E. Aksoy, V. Albarani, M. Nguyen et al., “Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells,” Blood, vol. 109, no. 7, pp. 2887–2893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  179. S. Goriely, B. Vincart, P. Stordeur et al., “Deficient IL-12(p35)gene expression by dendritic cells derived from neonatal monocytes,” Journal of Immunology, vol. 166, no. 3, pp. 2141–2146, 2001. View at Scopus
  180. S. Goriely, C. Van Lint, R. Dadkhah et al., “A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells,” Journal of Experimental Medicine, vol. 199, no. 7, pp. 1011–1016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  181. P. J. Vuillermin, A. L. Ponsonby, R. Saffery et al., “Microbial exposure, interferon gamma gene demethylation in naïve T-cells, and the risk of allergic disease,” Allergy, vol. 64, no. 3, pp. 348–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. O. Levy, M. Coughlin, B. N. Cronstein, R. M. Roy, A. Desai, and M. R. Wessels, “The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn,” Journal of Immunology, vol. 177, no. 3, pp. 1956–1966, 2006. View at Scopus
  183. J. H. Dalle, J. Menezes, E. Wagner et al., “Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections,” Pediatric Research, vol. 57, no. 5, pp. 649–655, 2005. View at Publisher · View at Google Scholar · View at Scopus
  184. Y. Wang, H. Xu, X. Zheng, H. Wei, R. Sun, and Z. Tian, “High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity,” Cellular & Molecular Immunology, vol. 4, no. 5, pp. 377–382, 2007. View at Scopus
  185. M. Krampera, L. Tavecchia, F. Benedetti, G. Nadali, and G. Pizzolo, “Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes,” Haematologica, vol. 85, no. 7, pp. 675–679, 2000. View at Scopus
  186. Y. Y. Fan, B. Y. Yang, and C. Y. Wu, “Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells,” Immunological Investigations, vol. 37, no. 1, pp. 79–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. J. Gaddy and H. E. Broxmeyer, “Cord blood CD16+56 cells with low lytic activity are possible precursors of mature natural killer cells,” Cellular Immunology, vol. 180, no. 2, pp. 132–142, 1997. View at Publisher · View at Google Scholar · View at Scopus
  188. S. S. Choi, V. S. Chhabra, Q. H. Nguyen, B. J. Ank, E. R. Stiehm, and R. L. Roberts, “Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 5, pp. 879–888, 2004. View at Publisher · View at Google Scholar · View at Scopus
  189. A. Nomura, H. Takada, C. H. Jin, T. Tanaka, S. Ohga, and T. Hara, “Functional analyses of cord blood natural killer cells and T cellsa distinctive interleukin-18 response,” Experimental Hematology, vol. 29, no. 10, pp. 1169–1176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  190. P. Satwani, J. Ayello, C. Van De Ven et al., “Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function,” British Journal of Haematology, vol. 130, no. 2, pp. 284–292, 2005. View at Publisher · View at Google Scholar · View at Scopus
  191. S. M. Wood, H. G. Ljunggren, and Y. T. Bryceson, “Insights into NK cell biology from human genetics and disease associations,” Cellular and Molecular Life Sciences, vol. 68, pp. 3479–3493, 2011.
  192. L. K. Dropulic and J. I. Cohen, “Severe viral infections and primary immunodeficiencies,” Clinical Infectious Diseases, vol. 53, pp. 897–909, 2011.
  193. J. E. Mold, S. Venkatasubrahmanyam, T. D. Burt et al., “Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans,” Science, vol. 330, no. 6011, pp. 1695–1699, 2010. View at Publisher · View at Google Scholar · View at Scopus
  194. Y. Ohshima and G. Delespesse, “T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells,” Journal of Immunology, vol. 158, no. 2, pp. 629–636, 1997. View at Scopus
  195. M. C. Mingari, E. Maggi, A. Cambiaggi et al., “Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10,” European Journal of Immunology, vol. 26, no. 5, pp. 1083–1087, 1996. View at Scopus
  196. G. P. White, P. M. Watt, B. J. Holt, and P. G. Holt, “Differential patterns of methylation of the IFN-γ promoter at CpG and non-CpG sites underlie differences in IFN-γ gene expression between human neonatal and adult CD45RO- T cells,” Journal of Immunology, vol. 168, no. 6, pp. 2820–2827, 2002. View at Scopus
  197. M. A. Fernandez, F. K. Puttur, Y. M. Wang, W. Howden, S. I. Alexander, and C. A. Jones, “T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice,” Journal of Immunology, vol. 180, no. 3, pp. 1556–1564, 2008. View at Scopus
  198. S. Ostrand-Rosenberg and P. Sinha, “Myeloid-derived suppressor cells: linking inflammation and cancer,” Journal of Immunology, vol. 182, no. 8, pp. 4499–4506, 2009. View at Publisher · View at Google Scholar · View at Scopus
  199. J. I. Youn and D. I. Gabrilovich, “The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity,” European Journal of Immunology, vol. 40, no. 11, pp. 2969–2975, 2010. View at Scopus
  200. E. Peranzoni, S. Zilio, I. Marigo et al., “Myeloid-derived suppressor cell heterogeneity and subset definition,” Current Opinion in Immunology, vol. 22, no. 2, pp. 238–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  201. I. Poschke and R. Kiessling, “On the armament and appearances of human myeloid-derived suppressor cells,” Clinical Immunology, vol. 144, pp. 250–268, 2012.
  202. D. I. Gabrilovich, S. Ostrand-Rosenberg, and V. Bronte, “Coordinated regulation of myeloid cells by tumours,” Nature Reviews Immunology, vol. 12, pp. 253–268, 2012.
  203. S. Ostrand-Rosenberg, P. Sinha, D. W. Beury, and V. K. Clements, “Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression,” Seminars in Cancer Biology, vol. 22, pp. 275–281, 2012.
  204. Y. Hayashi, T. Wada, and R. Mori, “Protection of newborn mice against herpes simplex virus infection by prenatal and postnatal transmission of antibody,” Journal of General Virology, vol. 64, no. 5, pp. 1007–1012, 1983. View at Scopus
  205. J. L. Yorty, S. A. Schultz, and R. H. Bonneau, “Postpartum maternal corticosterone decreases maternal and neonatal antibody levels and increases the susceptibility of newborn mice to herpes simplex virus-associated mortality,” Journal of Neuroimmunology, vol. 150, no. 1-2, pp. 48–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  206. I. A. C. Evans and C. A. Jones, “Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge,” Journal of Infectious Diseases, vol. 185, no. 11, pp. 1550–1560, 2002. View at Publisher · View at Google Scholar · View at Scopus
  207. A. S. Yeager, A. M. Arvin, L. J. Urbani, and J. A. Kemp, “Relationship of antibody to outcome in neonatal herpes simplex virus infections,” Infection and Immunity, vol. 29, no. 2, pp. 532–538, 1980. View at Scopus
  208. R. J. Whitley, A. J. Nahmias, and A. M. Visintine, “The natural history of herpes simplex virus infection of mother and newborn,” Pediatrics, vol. 66, no. 4, pp. 489–494, 1980. View at Scopus
  209. J. Kahlon and R. J. Whitley, “Antibody response of the newborn after herpes simplex virus infection,” Journal of Infectious Diseases, vol. 158, no. 5, pp. 925–933, 1988. View at Scopus
  210. Z. A. Brown, L. A. Vontver, and J. Benedetti, “Effects on infants of a first episode of genital herpes during pregnancy,” The New England Journal of Medicine, vol. 317, no. 20, pp. 1246–1251, 1987. View at Scopus
  211. L. R. Stanberry, “Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines,” Herpes, vol. 11, no. 3, pp. 161A–169A, 2004. View at Scopus
  212. R. B. Belshe, P. A. Leone, D. I. Bernstein, A. Wald, M. J. Levin, et al., “Efficacy results of a trial of a herpes simplex vaccine,” The New England Journal of Medicine, vol. 366, pp. 34–43, 2012.
  213. L. Corey, A. G. M. Langenberg, R. Ashley et al., “Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials,” Journal of the American Medical Association, vol. 282, no. 4, pp. 331–340, 1999. View at Publisher · View at Google Scholar · View at Scopus
  214. L. R. Stanberry, S. L. Spruance, A. L. Cunningham et al., “Glycoprotein-D-adjuvant vaccine to prevent genital herpes,” The New England Journal of Medicine, vol. 347, no. 21, pp. 1652–1661, 2002. View at Publisher · View at Google Scholar · View at Scopus
  215. A. J. Lee and A. A. Ashkar, “Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development,” Current Opinion in Infectious Diseases, vol. 25, pp. 92–99, 2012.
  216. S. E. Straus, L. Corey, R. L. Burke et al., “Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes,” The Lancet, vol. 343, no. 8911, pp. 1460–1463, 1994. View at Publisher · View at Google Scholar · View at Scopus
  217. H. Shin and A. Iwasaki, “A vaccine strategy that protects against genital herpes by establishing local memory T cells,” Nature, vol. 491, pp. 463–467, 2012. View at Publisher · View at Google Scholar
  218. K. Olson, P. Macias, S. Hutton, W. A. Ernst, G. Fujii, and J. P. Adler-Moore, “Liposomal gD ectodomain (gD1−306) vaccine protects against HSV2 genital or rectal infection of female and male mice,” Vaccine, vol. 28, no. 2, pp. 548–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  219. L. Macmillan, G. O. Ifere, Q. He et al., “A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes,” FEMS Immunology and Medical Microbiology, vol. 49, no. 1, pp. 46–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  220. I. Bettahi, X. Zhang, R. E. Afifi, and L. Benmohamed, “Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response,” Viral Immunology, vol. 19, no. 2, pp. 220–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  221. C. S. Morello, M. S. Levinson, K. A. Kraynyak, and D. H. Spector, “Immunization with Herpes Simplex Virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease,” Journal of Virology, vol. 85, no. 7, pp. 3461–3472, 2011. View at Publisher · View at Google Scholar · View at Scopus
  222. A. S. Kask, X. Chen, J. O. Marshak et al., “DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge,” Vaccine, vol. 28, no. 47, pp. 7483–7491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  223. T. Dudek and D. M. Knipe, “Replication-defective viruses as vaccines and vaccine vectors,” Virology, vol. 344, no. 1, pp. 230–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  224. D. M. Koelle, “Vaccines for herpes simplex virus infections,” Current Opinion in Investigational Drugs, vol. 7, no. 2, pp. 136–141, 2006. View at Scopus
  225. Y. Hoshino, S. K. Dalai, K. Wang et al., “Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs,” Journal of Virology, vol. 79, no. 1, pp. 410–418, 2005. View at Publisher · View at Google Scholar · View at Scopus
  226. N. J. Reszka, T. Dudek, and D. M. Knipe, “Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein,” Vaccine, vol. 28, no. 15, pp. 2754–2762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  227. W. P. Halford, R. Püschel, E. Gershburg, A. Wilber, S. Gershburg, and B. Rakowski, “A live-attenuated HSV-2 ICP0- virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine,” PloS ONE, vol. 6, no. 3, Article ID e17748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  228. S. Awasthi, E. E. Zumbrun, H. Si, F. Wang, C. E. Shaw, et al., “Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread,” Journal of Virology, vol. 86, pp. 4586–4598, 2012.
  229. R. Brans and F. Yao, “Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs,” BMC Microbiology, vol. 10, article 163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  230. J. E. Schrimpf, E. M. Tu, H. Wang, Y. M. Wong, and L. A. Morrison, “B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease,” PloS ONE, vol. 6, no. 8, Article ID e22772, 2011. View at Publisher · View at Google Scholar · View at Scopus
  231. S. P. Vagvala, L. G. Thebeau, S. R. Wilson, and L. A. Morrison, “Virus-encoded B7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice,” Journal of Virology, vol. 83, no. 2, pp. 953–960, 2009. View at Publisher · View at Google Scholar · View at Scopus
  232. S. W. Lee, P. F. Markham, M. J. Coppo, A. R. Legione, J. F. Markham, et al., “Attenuated vaccines can recombine to form virulent field viruses,” Science, vol. 337, article 188, 2012.
  233. M. de Veer and E. Meeusen, “New developments in vaccine research—unveiling the secret of vaccine adjuvants,” Discovery Medicine, vol. 12, pp. 195–204, 2011.
  234. F. Superti, M. G. Ammendolia, and M. Marchetti, “New advances in anti-HSV chemotherapy,” Current Medicinal Chemistry, vol. 15, no. 9, pp. 900–911, 2008. View at Publisher · View at Google Scholar · View at Scopus
  235. L. V. Kovalchuk, L. V. Gankovskaya, O. A. Gankovskaya, and V. F. Lavrov, “Herpes simplex virus: treatment with antimicrobial peptides,” Advances in Experimental Medicine and Biology, vol. 601, pp. 369–376, 2007. View at Scopus
  236. R. B. Basak, V. Malpani, K. Kakish, S. Vargese, N. Chauhan, et al., “Poor neurological sequelae of herpes simplex virus encephalitis in an infant despite adequate antiviral and adjunct corticosteroid therapy,” Indian Journal of Dermatology, vol. 56, pp. 749–751, 2011.
  237. H. Openshaw and E. M. Cantin, “Corticosteroids in herpes simplex virus encephalitis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 11, pp. 1469–1471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  238. J. P. Wang, G. N. Bowen, S. Zhou, A. Cerny, A. Zacharia, et al., “Role of specific innate immune responses in herpes simplex virus infection of the central nervous system,” Journal of Virology, vol. 86, pp. 2273–2281, 2012.
  239. A. H. J. van den Biggelaar, S. L. Prescott, M. Roponen et al., “Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations,” Journal of Allergy and Clinical Immunology, vol. 124, no. 3, pp. 544.e2–550.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus